-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
- Cosmetic Ingredient
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Non-alcoholic fatty liver disease (NAFLD) is one of the most common chronic liver diseases in the United States, with an estimated prevalence of 30%
.
Although NAFLD patients usually do not require medication, non-alcoholic steatohepatitis (NASH) increases the risk of advanced liver complications such as liver fibrosis, cirrhosis, and hepatocellular carcinoma (HCC)
Non-alcoholic fatty liver disease (NAFLD) is one of the most common chronic liver diseases in the United States, with an estimated prevalence of 30%
Obesity is an important risk factor for a variety of cancers, including HCC, colon cancer , rectal cancer, esophageal cancer, and pancreatic cancer
.
NAFLD is an independent risk factor for multiple cancers
Colon cancer pancreatic cancerStomach cancer
Researchers collected newly diagnosed severely obese NAFLD patients from 2007 to 2017 and conducted a retrospective cohort study
.
Use the Cox proportional hazards model to examine the risk factors associated with bariatric surgery and any cancer
Diagnosing colorectal cancer
Figure: The impact of bariatric surgery on the incidence of cancer
In NAFLD patients with severe obesity, bariatric surgery is associated with a significantly reduced risk of obesity-related cancers
.
.
Original source:
Vinod K.
Bariatric Surgery Reduces Cancer Risk in Adults With Nonalcoholic Fatty Liver Disease and Severe Obesity.
Leave a message here
